New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel
... that requires the use of cytochrome P450 (CYP) enzymes to convert the drug into the active metabolite. ... which is part of the CYP system and encodes the enzymes that are responsible for converting prasugrel ... associations for major cytochrome P450 enzymes in native and first- and third-generation ...DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines
... enzyme discovery and development to identify new enzymes for efficient conversion of a large spectrum of ... DSM will produce the enzymes at industrial scale using DSM's fermentation ... platform, PluGbug(TM). LibraGen will sell the enzymes in kit form and both parties will use them for ...Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
... Clinically significant elevations of liver enzymes were observed in approximately eight percent of ... and ribavirin. In contrast, elevated liver enzymes were seen in only one percent of patients on standard of care. Elevations of liver enzymes appear to be transient in some patients. The U.S. ...EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health
... -- EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it ... properties. EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann ...Mutant Genes in High-Risk Childhood Leukemias Identified
... some high-risk ALL cases might arise from mutations in genes that produce enzymes called kinases, which function as biological on-off switches in cells," ... the researchers plan to identify mutations in kinase genes and other enzymes that underlie high-risk ALL, as well as explore how these abnormalities ...New Insight Into the Controls on a Go-To Enzyme
... to calpain and inhibiting it --- essentially ignoring other highly similar enzymes in the cell. In an article published in the November 20, 2008, ... recognize only calpains, rather than mistakenly attach to other similar enzymes in the cell. Furthermore, the researchers discovered how ...New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
... enzymes, respectively. Both ESBL and AmpC Beta-lactamase are enzymes that destroy cephalosporins and other related antibiotics. Approximately, ... Enterobacter spp., indole-positive Proteae and Serratia spp. ESBL and AmpC enzymes had little impact on doripenem MIC(50) potencies (up to two-fold). ...Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... with Baxter International Inc. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... with Baxter International Inc. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
... Mostaghel said. "As we develop new drug targets, we will need to focus on enzymes that seem to be active in the tumor tissue itself. This offers a new way ... of progesterone to testosterone precursors, as well as inhibitors of enzymes that perform subsequent steps in testosterone production: AKR1C3 and ...Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
... PCI-24781 has been shown to inhibit all forms of HDAC enzymes to target a broad range of cancer types, including colon, breast, ... About HDAC Inhibitors Histone deacetylases are a family of related enzymes important in managing a multitude of cellular functions. HDAC inhibitors ...Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
... of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze Technology is a novel drug ... injected drugs and fluids. The company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
... of disease cells. Extensive screening against a panel of 73 kinase enzymes indicates that CYT387 possesses selectivity for JAK2, potentially ... and New York and specializes in discovering new molecules that can inhibit enzymes known as kinases, an exciting new class of drugs. ...NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and response to cigarette smoke exposure. ... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and response to cigarette smoke exposure. ...VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
... selective inhibitor of SHP-1 and SHP-2. Inhibition of these key regulatory enzymes results in the up-regulation of the response to immunologic stimuli ... preclinical studies conducted at the Cleveland Clinic. These intracellular enzymes are involved in signaling pathways of many receptor-linked tyrosine ...NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and is frequently a response to exposure to ... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and response to exposure to cigarette smoke. ...Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
... and lower respiratory tract were the only other infections or adverse events that occurred in 5 percent or more of patients. Elevations of liver enzymes and bilirubin were noted, but were not characteristic of drug-induced liver injury and were judged to be not related to vicriviroc. These infections ...Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
... immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has ...TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR
... whereas CleanAmp(TM) dNTPs will be a more general solution. Either product will provide a very cost effective solution when compared to the modified enzymes available on the market." About TriLink TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, nucleoside triphosphates and ...Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
... and large proteins across the endothelial membrane in the BBB. NeuroTrans(TM) has also been conjugated to a variety of protein drugs, including enzymes and growth factors, without interfering with their therapeutic functions. About Raptor Pharmaceuticals Corp. Raptor Pharmaceuticals ...Autism Genes Discovered; Help Shape Connections Among Brain Cells
... first study. The other gene cluster impacted by copy number variations belongs to the ubiquitin degradation pathway. Ubiquitins are a class of enzymes that eliminate connections among nerve cells, and are involved with processing and degrading neuronal cell-adhesion molecules -- thus linking the ...Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
... of metabolism present in an estimated 1 in 10,000 births in the United States. Patients with urea cycle disorders are deficient in one of the key enzymes that comprise the urea cycle, the body's primary vehicle for removing ammonia, a potent neurotoxin, from the bloodstream. Onset may occur at any age ...